PREVENTION OF POST PARTUM HAEMORRHAGE BY RECTAL MISOPROSTOL. A RANDOMISED CONTROLLED TRIAL.

Discussion
In developing countries postpartum haemorrhage is regarded as one of the major causes of maternal mortality and morbidity. Consequently, the active management of the third stage of labour should be practiced along with the routine use of intravenous oxytocin. To substitute for oxytocin and to prevent postpartum haemorrhage misoprostol was chosen because it has similar advantages but with minimal side effects, low shelf life.

The rectal route has been chosen because of the ease of administration, and can avoid the gastrointestinal side effects of nausea, vomiting, and diarrhoea, so it can be given to a nauseated women. The results of our study met the our expectations where the blood loss did not exceed the incidence in our hospital ~7% where we use the routine method of active management of third stage of labour along with oxytocin intravenously.

Recent studies has shown that rectal misoprostol is useful in the treatment of third stage of labour and may be effective in the treatment of postpartum haemorrhage (11-13)
Karkanis et al. studied 240 women who randomly received 400 micrograms rectal misoprostol after delivery of the infant or parenteral oxytocin5 units intravenously or 10 units intramuscularly) with the delivery of the anterior shoulder. No difference in Hb was observed between the groups. The duration of the third stage of labour did not differ between the two groups.(13)

In a trial done by Bugalh et al., 663 women with uncomplicated vaginal delivery were randomised to receive 400 micrograms rectal misoprostol or oxytocin 10 IU IM after delivery of he infant. No significant differences were observed between groups, before and 72 hours after delivery. He concluded that rectal misoprostol appears to be effective as parenteral oxytocin in preventing postpartum haemorrhage.(10)
Bamigboye et al. (12) in his search for an effective, easily stored, affordable uterotonic agent to prevent postpartum haemorrhage, underwent a trial where he randomised 491 women to receive either 400 micrograms rectal misoprostol (241 women) or one ampule of syntometrin (250 women). His results showed that he incidence of postpartum hemorrhge, duration of third stage of labour and the drop in Hb were similar.

Rectal misoprostol in one tablet was used by Shoja et al. (13) to stop severe delivery induced haemorrhage on uterine atony after failure of syntocinon. In all the five patients studied haemorrhage ceased in less than 5 minutes with no immediate side effects observed. This finding suggests that rectal misoprostol might be used for the control of severe postpartum haemorrhage, which failed to cease by the ordinary uterotonic agents.